Global Mecobalamin (Methylcobalamin) API Market Growth 2024-2030

Publication ID:

LPI07245879

Publication Date:

July 18, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Methylcobalamin (mecobalamin, MeCbl, or MeB12) is a cobalamin, a form of vitamin B12. It differs from cyanocobalamin in that the cyano group at the cobalt is replaced with a methyl group. Methylcobalamin features an octahedral cobalt(III) centre and can be obtained as bright red crystals.
The global Mecobalamin (Methylcobalamin) API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淢ecobalamin (Methylcobalamin) API Industry Forecast鈥� looks at past sales and reviews total world Mecobalamin (Methylcobalamin) API sales in 2023, providing a comprehensive analysis by region and market sector of projected Mecobalamin (Methylcobalamin) API sales for 2024 through 2030. With Mecobalamin (Methylcobalamin) API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mecobalamin (Methylcobalamin) API industry.
This Insight Report provides a comprehensive analysis of the global Mecobalamin (Methylcobalamin) API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mecobalamin (Methylcobalamin) API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Mecobalamin (Methylcobalamin) API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mecobalamin (Methylcobalamin) API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mecobalamin (Methylcobalamin) API.
United States market for Mecobalamin (Methylcobalamin) API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Mecobalamin (Methylcobalamin) API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Mecobalamin (Methylcobalamin) API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Mecobalamin (Methylcobalamin) API players cover EUROAPI, Eisai Co., Ltd, HTBA, Cspc Holdings Company, Ningxia Kingvit Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Mecobalamin (Methylcobalamin) API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity 鈮�99%
Purity <99%
Segmentation by Application:
Oral Formulation
Injectable Formulation
Sprays
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
EUROAPI
Eisai Co., Ltd
HTBA
Cspc Holdings Company
Ningxia Kingvit Pharmaceutical
Yufeng Industry Group
North China Pharmaceutical Company
Key Questions Addressed in this Report
What is the 10-year outlook for the global Mecobalamin (Methylcobalamin) API market?
What factors are driving Mecobalamin (Methylcobalamin) API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mecobalamin (Methylcobalamin) API market opportunities vary by end market size?
How does Mecobalamin (Methylcobalamin) API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mecobalamin (Methylcobalamin) API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Mecobalamin (Methylcobalamin) API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Mecobalamin (Methylcobalamin) API by Country/Region, 2019, 2023 & 2030
2.2 Mecobalamin (Methylcobalamin) API Segment by Type
2.2.1 Purity 鈮�99%
2.2.2 Purity <99%
2.3 Mecobalamin (Methylcobalamin) API Sales by Type
2.3.1 Global Mecobalamin (Methylcobalamin) API Sales Market Share by Type (2019-2024)
2.3.2 Global Mecobalamin (Methylcobalamin) API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Mecobalamin (Methylcobalamin) API Sale Price by Type (2019-2024)
2.4 Mecobalamin (Methylcobalamin) API Segment by Application
2.4.1 Oral Formulation
2.4.2 Injectable Formulation
2.4.3 Sprays
2.5 Mecobalamin (Methylcobalamin) API Sales by Application
2.5.1 Global Mecobalamin (Methylcobalamin) API Sale Market Share by Application (2019-2024)
2.5.2 Global Mecobalamin (Methylcobalamin) API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Mecobalamin (Methylcobalamin) API Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Mecobalamin (Methylcobalamin) API Breakdown Data by Company
3.1.1 Global Mecobalamin (Methylcobalamin) API Annual Sales by Company (2019-2024)
3.1.2 Global Mecobalamin (Methylcobalamin) API Sales Market Share by Company (2019-2024)
3.2 Global Mecobalamin (Methylcobalamin) API Annual Revenue by Company (2019-2024)
3.2.1 Global Mecobalamin (Methylcobalamin) API Revenue by Company (2019-2024)
3.2.2 Global Mecobalamin (Methylcobalamin) API Revenue Market Share by Company (2019-2024)
3.3 Global Mecobalamin (Methylcobalamin) API Sale Price by Company
3.4 Key Manufacturers Mecobalamin (Methylcobalamin) API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mecobalamin (Methylcobalamin) API Product Location Distribution
3.4.2 Players Mecobalamin (Methylcobalamin) API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Mecobalamin (Methylcobalamin) API by Geographic Region
4.1 World Historic Mecobalamin (Methylcobalamin) API Market Size by Geographic Region (2019-2024)
4.1.1 Global Mecobalamin (Methylcobalamin) API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Mecobalamin (Methylcobalamin) API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Mecobalamin (Methylcobalamin) API Market Size by Country/Region (2019-2024)
4.2.1 Global Mecobalamin (Methylcobalamin) API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Mecobalamin (Methylcobalamin) API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Mecobalamin (Methylcobalamin) API Sales Growth
4.4 APAC Mecobalamin (Methylcobalamin) API Sales Growth
4.5 Europe Mecobalamin (Methylcobalamin) API Sales Growth
4.6 Middle East & Africa Mecobalamin (Methylcobalamin) API Sales Growth
5 Americas
5.1 Americas Mecobalamin (Methylcobalamin) API Sales by Country
5.1.1 Americas Mecobalamin (Methylcobalamin) API Sales by Country (2019-2024)
5.1.2 Americas Mecobalamin (Methylcobalamin) API Revenue by Country (2019-2024)
5.2 Americas Mecobalamin (Methylcobalamin) API Sales by Type (2019-2024)
5.3 Americas Mecobalamin (Methylcobalamin) API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mecobalamin (Methylcobalamin) API Sales by Region
6.1.1 APAC Mecobalamin (Methylcobalamin) API Sales by Region (2019-2024)
6.1.2 APAC Mecobalamin (Methylcobalamin) API Revenue by Region (2019-2024)
6.2 APAC Mecobalamin (Methylcobalamin) API Sales by Type (2019-2024)
6.3 APAC Mecobalamin (Methylcobalamin) API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mecobalamin (Methylcobalamin) API by Country
7.1.1 Europe Mecobalamin (Methylcobalamin) API Sales by Country (2019-2024)
7.1.2 Europe Mecobalamin (Methylcobalamin) API Revenue by Country (2019-2024)
7.2 Europe Mecobalamin (Methylcobalamin) API Sales by Type (2019-2024)
7.3 Europe Mecobalamin (Methylcobalamin) API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mecobalamin (Methylcobalamin) API by Country
8.1.1 Middle East & Africa Mecobalamin (Methylcobalamin) API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Mecobalamin (Methylcobalamin) API Revenue by Country (2019-2024)
8.2 Middle East & Africa Mecobalamin (Methylcobalamin) API Sales by Type (2019-2024)
8.3 Middle East & Africa Mecobalamin (Methylcobalamin) API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mecobalamin (Methylcobalamin) API
10.3 Manufacturing Process Analysis of Mecobalamin (Methylcobalamin) API
10.4 Industry Chain Structure of Mecobalamin (Methylcobalamin) API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mecobalamin (Methylcobalamin) API Distributors
11.3 Mecobalamin (Methylcobalamin) API Customer
12 World Forecast Review for Mecobalamin (Methylcobalamin) API by Geographic Region
12.1 Global Mecobalamin (Methylcobalamin) API Market Size Forecast by Region
12.1.1 Global Mecobalamin (Methylcobalamin) API Forecast by Region (2025-2030)
12.1.2 Global Mecobalamin (Methylcobalamin) API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Mecobalamin (Methylcobalamin) API Forecast by Type (2025-2030)
12.7 Global Mecobalamin (Methylcobalamin) API Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 EUROAPI
13.1.1 EUROAPI Company Information
13.1.2 EUROAPI Mecobalamin (Methylcobalamin) API Product Portfolios and Specifications
13.1.3 EUROAPI Mecobalamin (Methylcobalamin) API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 EUROAPI Main Business Overview
13.1.5 EUROAPI Latest Developments
13.2 Eisai Co., Ltd
13.2.1 Eisai Co., Ltd Company Information
13.2.2 Eisai Co., Ltd Mecobalamin (Methylcobalamin) API Product Portfolios and Specifications
13.2.3 Eisai Co., Ltd Mecobalamin (Methylcobalamin) API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eisai Co., Ltd Main Business Overview
13.2.5 Eisai Co., Ltd Latest Developments
13.3 HTBA
13.3.1 HTBA Company Information
13.3.2 HTBA Mecobalamin (Methylcobalamin) API Product Portfolios and Specifications
13.3.3 HTBA Mecobalamin (Methylcobalamin) API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 HTBA Main Business Overview
13.3.5 HTBA Latest Developments
13.4 Cspc Holdings Company
13.4.1 Cspc Holdings Company Company Information
13.4.2 Cspc Holdings Company Mecobalamin (Methylcobalamin) API Product Portfolios and Specifications
13.4.3 Cspc Holdings Company Mecobalamin (Methylcobalamin) API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cspc Holdings Company Main Business Overview
13.4.5 Cspc Holdings Company Latest Developments
13.5 Ningxia Kingvit Pharmaceutical
13.5.1 Ningxia Kingvit Pharmaceutical Company Information
13.5.2 Ningxia Kingvit Pharmaceutical Mecobalamin (Methylcobalamin) API Product Portfolios and Specifications
13.5.3 Ningxia Kingvit Pharmaceutical Mecobalamin (Methylcobalamin) API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Ningxia Kingvit Pharmaceutical Main Business Overview
13.5.5 Ningxia Kingvit Pharmaceutical Latest Developments
13.6 Yufeng Industry Group
13.6.1 Yufeng Industry Group Company Information
13.6.2 Yufeng Industry Group Mecobalamin (Methylcobalamin) API Product Portfolios and Specifications
13.6.3 Yufeng Industry Group Mecobalamin (Methylcobalamin) API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Yufeng Industry Group Main Business Overview
13.6.5 Yufeng Industry Group Latest Developments
13.7 North China Pharmaceutical Company
13.7.1 North China Pharmaceutical Company Company Information
13.7.2 North China Pharmaceutical Company Mecobalamin (Methylcobalamin) API Product Portfolios and Specifications
13.7.3 North China Pharmaceutical Company Mecobalamin (Methylcobalamin) API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 North China Pharmaceutical Company Main Business Overview
13.7.5 North China Pharmaceutical Company Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂